Bausch + Lomb announced the appointment of Brent Saunders as CEO and chair of the Board of Directors of the company, effective March 6. Concurrent with this appointment, and as previously announced, Joseph Papa will step down from his roles as CEO and director. Additionally, effective upon Saunders’ appointment as chair of the Board, Thomas Ross, Sr. will become the Lead Independent Director of the Board. To facilitate an orderly transition, Saunders will join Bausch + Lomb on Feb. 16 in an advisory capacity, where he will work closely with Papa. Saunders will return to Bausch + Lomb after having served at the company as CEO from 2010 to 2013. In total, he brings more than 25 years of leadership in health care, having served in president, CEO and chairman roles, among others, at several global pharmaceutical and health care companies, including Schering-Plough Corporation, Forest Laboratories Inc., Actavis plc, Allergan plc and The Beauty Health Company.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on BLCO: